A surge in demand for COVID-19 tests and vaccines helped Walgreens deliver a better second quarter than Wall Street expectedA surge in demand for COVID-19 tests and vaccines helped Walgreens deliver a better second quarter than Wall Street expected. But that boost from the ongoing pandemic isn't expected to last, and the drugstore chain stuck to a 2022 outlook issued earlier. Company leaders also told analysts that Walgreens' big shift into delivering more care was too recent to see measurable growth in prescriptions or customer store visits. Walgreens CEO Rosalind Brewer said in January that the company was exploring “strategic options” for Boots, which it acquired several years ago. Walgreens pulls in most of its revenue from retail pharmacies in the U.S., where it runs nearly 9,000 stores.

Source: ABC News April 01, 2022 00:38 UTC